The rebrand to Sampled has helped us further integrate our services and laying a strong foundation to continue investing in expanding our capabilities and international presence.”
In 2021, the company acquired Roylance Pharma, a leader in biomaterial expertise, expanding its footprint with a UK hub to better service Europe.Īmit Bhalla, Sampled Chief Financial Officer, said: “In the last two years, we drove incredible growth across our core services while also demonstrating our ability to quickly scale up during the COVID-19 crisis. In May of 2020, the company developed the first COVID-19 test utilizing saliva, for which it received FDA emergency use authorization and became the first company to offer at-home collection with this methodology. Since commercializing outside of Rutgers in 2020, the company has rapidly expanded its capabilities and partnerships, while launching several ground-breaking new products. With our proven technology and deep expertise, Sampled aims to be the SMART lab behind every new transformative health innovation.” Robin Grimwood, Sampled Chief Executive Officer, said: “At Sampled, we play a vital role in improving human health by offering the quality, speed and scale our partners need to develop and bring products to market faster. Through its integrated “SMART Labs” services, the company can Store, Manage, Analyze, Research and Transport biological materials, offering partners a seamless solution for all research samples. By focusing on the genetic causes of common, complex diseases, Sampled aims to discover diagnoses, treatments and, eventually, cures. Sampled is a next-generation laboratory that unlocks valuable data from any biological sample. PISCATAWAY, N.J.-( BUSINESS WIRE)-Today Infinity Biologix (IBX) and Roylance Pharma announced the rebrand of both organisations as “Sampled”.
0 kommentar(er)
